Monoclonal Antibody Reduces Exacerbations In Asthmatics

Armen Hareyan's picture

Treatment of Symptoms of Asthma

Patients with symptomatic moderate asthma who were treated with anti-tumor necrosis factor alpha, an anti-inflammatory monoclonal antibody, experienced significantly fewer

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.